Log in

4901 FUJIFILM Holdings Corp TSE · Japan

FUJIFILM Holdings (4901) news

FUJIFILM Holdings Corp is a public biotech or pharmaceutical company listed on TSE under the ticker 4901, recorded under Japan. The directory classifies it as Diversified biotechnology / therapeutics. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest FUJIFILM Holdings news

We have not published a story on FUJIFILM Holdings yet. When there is news, it will appear here.

Questions about FUJIFILM Holdings

What is the ticker symbol of FUJIFILM Holdings?

FUJIFILM Holdings Corp trades under the ticker 4901 on TSE.

Where is FUJIFILM Holdings listed?

FUJIFILM Holdings Corp is listed on TSE.

Which country or territory is FUJIFILM Holdings listed under?

Our directory records FUJIFILM Holdings Corp under Japan.

What does FUJIFILM Holdings do?

Our directory classifies FUJIFILM Holdings Corp as: Diversified biotechnology / therapeutics. This is a directory classification, not a description of the pipeline.

What is the ISIN of FUJIFILM Holdings?

The ISIN recorded for FUJIFILM Holdings Corp is JP3814000000.

Does aibio.space cover FUJIFILM Holdings?

aibio.space lists FUJIFILM Holdings Corp among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to FUJIFILM Holdings?

Companies in our directory listed in the same country and business area as FUJIFILM Holdings: Renascience, Mochida Pharmaceutical Co., Chordia Therapeutics, Asahi Kasei, Earth, StemCell Institute.

Investor discussion: FUJIFILM Holdings

Members talk about FUJIFILM Holdings (4901). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open TSE:4901 on TradingView.

Listing details

FUJIFILM Holdings Corp is a public biotech or pharmaceutical company listed on TSE under the ticker 4901, recorded under Japan. The directory classifies it as Diversified biotechnology / therapeutics. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
FUJIFILM Holdings Corp
Ticker
4901
Listing
TSE
Country or territory
Japan
Business scope
Diversified biotechnology / therapeutics
ISIN
JP3814000000
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.